50 mg/g (5%), eye gel
Dexpanthenolum
The active substance of the medicine is dexpanthenol.
The medicine is used to treat non-inflammatory keratopathy, e.g.: corneal degeneration, corneal dystrophy,
recurrent erosion and damage related to contact lens use.
Additionally, as a supportive treatment for corneal and conjunctival injuries, chemical burns and burns.
Supportively in specific treatment of bacterial, fungal and viral corneal damage.
WARNING:
Corneregel is not intended for the treatment of bacterial, fungal and viral corneal damage, but only as a supportive treatment for these corneal diseases.
Tell your doctor or pharmacist about all medicines the patient is taking or has recently taken, as well as any medicines the patient plans to take.
If Corneregel is used at the same time as other eye drops/ointments, a minimum of 15 minutes should be allowed between administration of these medicines, and Corneregel should always be administered last.
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult their doctor or pharmacist before using this medicine.
The medicine should not be used during pregnancy, unless advised by a doctor.
Corneregel, even if used correctly, may temporarily blur vision due to the formation of streaks, and may affect the ability to react. The patient should not drive vehicles, perform tasks without stable support, or operate machines until the symptoms have resolved.
This medicine should always be used exactly as advised by your doctor or pharmacist. If you are unsure, consult your doctor or pharmacist.
For use in the eye.
Recommended dose:
Depending on the severity and intensity of the disorder, 1 drop into the conjunctival sac 4 times a day, and also 1 drop before bedtime.
There are no time limits for use. The medicine can be used until the subjective symptoms have resolved.
Wash your hands.
Tilt your head back and gently pull down the lower eyelid with your index finger.
With your other hand, position the tube vertically over the eye.
surfaces.This can lead to infection of the gel. Using infected gel can lead to dangerous complications and even vision loss.
Administer one drop into the conjunctival sac.
If the drop does not enter the eye, try again.
After administration, try to keep the eye open and move it so that the gel is evenly distributed.
Administration of a larger amount of the medicine than recommended is not associated with any additional risk.
A double dose should not be used to make up for a missed dose.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Very rare side effects (may affect up to 1 in 10,000 people): hypersensitivity reactions (e.g., itching, rash).
Side effects of unknown frequency include: eye irritation, e.g., redness, pain, feeling of a foreign body in the eye, tearing, eye itching, conjunctival edema.
If you experience any side effects, including any side effects not listed in this leaflet, tell your doctor or pharmacist. Side effects can be reported directly to the Department of Monitoring of Adverse Reactions to Medicinal Products of the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products,
Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309,
website: https://smz.ezdrowie.gov.pl.
Reporting side effects will help to gather more information on the safety of the medicine.
Keep the medicine out of sight and reach of children.
Do not store above 25°C.
Do not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the stated month.
Discard any remaining contents 4 weeks after first opening the tube.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Corneregel is an eye gel. The medicine is supplied in a tube in a cardboard box.
Pack size: 10 g of gel.
For more detailed information, consult the marketing authorization holder or parallel importer.
Bausch + Lomb Ireland Limited
3013 Lake Drive
Citywest Business Campus 24
Dublin, Ireland
Dr. Mann Chem.-Pharm. Fabrik GmbH
Brunsbütteler Damm 165-173
InPharm Sp. z o.o.
ul. Strumykowa 28/11
03-138 Warsaw
InPharm Sp. z o.o. Services sp. k.
ul. Chełmżyńska 249
04-458 Warsaw
Authorization number in Greece, the country of export:76459/21-12-2015
Parallel import authorization number:207/09
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.